Oral administration of a 2-aminopyrimidine robenidine analogue (NCL195) significantly reduces Staphylococcus aureus infection and reduces Escherichia coli infection in combination with sub-inhibitory colistin concentrations in a bioluminescent mouse model

- Nguyen, Hang Thi, Venter, Henrietta, Woolford, Lucy, Young, Kelly A., Mccluskey, Adam, Garg, Sanjay, Sapula, Sylvia S., Page, Stephen W., Ogunniyi, Abiodun David, Trott, Darren J.

The Gram-negative permeability barrier: tipping the balance of the in and the out

- Maher, Claire, Hassan, Karl A.

Comparison of two transmission electron microscopy methods to visualize drug-induced alterations of gram-negative bacterial morphology

- Nguyen, Hang Thi, O'Donovan, Lisa A., Venter, Henrietta, Russell, Cecilia C., McCluskey, Adam, Page, Stephen W., Trott, Darren J., Ogunniyi, Abiodun D.

In vitro synergistic activity of NCL195 in combination with colistin against Gram-negative bacterial pathogens

- Nguyen, Hang Thi, Venter, Henrietta, Veltman, Tania, Williams, Ruth, O'Donovan, Lisa Anne, Russell, Cecilia C., McCluskey, Adam, Page, Stephen W., Ogunniyi, Abiodun David, Trott, Darren J.

Molecular characterization of lipopolysaccharide binding to human α-1-acid glycoprotein

- Huang, Johnny X., Azad, Mohammad A. K., Yuriev, Elizabeth, Baker, Mark A., Nation, Roger L., Li, Jian, Cooper, Matthew A., Velkov, Tony